Cardiology Month in Review: October 2021

Editor's Note: Clicking in the center of a slide will redirect you to the article highlighted within that slide.

Top Stories of October 2021:

1. Aspirin's Role in Cardiovascular Prevention With Guy Mintz, MD
   In a Q&A, Guy Mintz, MD, provides perspective on the USPSTF draft recommendations surrounding aspirin for primary and secondary prevention, how the role of aspirin has evolved in recent decades, and how the news has caused a surge of questions in his practice.
   
2. Take-Home Messages from New Chest Pain Guidelines, with Martha Gulati, MD
   Chair of the guideline's writing committee Martha Gulati, MD, MS, offers perspective into the 10 take-home messages the guideline authors chose to highlight within the ACC/AHA 2021 chest pain guidelines.
3. Meta-Analysis Raises Questions Around Risk of Atrial Fibrillation Associated with Omega-3 Supplements
   A meta-analysis and systematic review of 7 RCTs suggests consuming more than 1 gram of marine omega-3 fatty acid supplements per day could increase a patient's risk of atrial fibrillation.
   
4. Recognizing the Role of PAs in Cardiology With Viet Le, PA-C
   To celebrate National Physician Assistant Week, we reached out to the president of the Association of Physician Assistants in Cardiology for his perspective on the holiday and to reflect on the evolving role of PAs in cardiology.
5. Israeli Study Details Myocarditis Risk Associated with Pfizer COVID-19 Vaccine
   An analysis of more than 9 million patients, including more than 5 million receiving both doses, provides insight into the risks of myocarditis associated with the BNT162b2 COVID-19 vaccine.
   
6. Optimizing Heart Failure Management
   A panel of experts discuss the many ways therapies used to manage heart failure are beneficial, as well as what steps can be taken to improve patients’ responses and their quality of life.